Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wellness and peer support may boost HIV care for India's sexual minorities

NCT ID NCT05869461

Ongoing Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study adapts a wellness program called Chetana to help men who have sex with men (MSM) and transgender women (TGW) in India who are living with HIV stay engaged in care. The program includes yoga, nutrition, legal advice, mental health support, and peer navigators who provide flexible, personalized help. Researchers are testing whether this approach is acceptable and feasible in a small randomized trial, with the goal of improving appointment keeping, medication adherence, and viral suppression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a wellness program including yoga, nutrition, legal support, mental health, and peer navigation
What this could lead to
If successful, this approach could improve HIV care engagement and viral suppression among marginalized groups in India.
What could go wrong
This is a small pilot study, so results may not be generalizable. The intervention may not work as well in larger or different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TREATMENT ADHERENCE

Contacts and locations

Locations

  • The Humsafar Trust

    Mumbai, 400055, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.